ODDB.org: Open Drug Database

Amgen Switzerland AG - MVASI 400 mg/16 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	67283	Sequence	02
Product name	MVASI 400 mg/16 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FG01	ATC-Description
Introduction of Sequence	09.12.2019

Composition

bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 21.68 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Bevacizumab	400mg / 16ml

BAG: Active Agent	Dose
Bevacizumab	400 mg

Inactive agents
Disodium Phosphate
Sodium Dihydrogenophosphate Monohydrate
Polysorbatum 20
Trehalosum Dihydricum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
002		962.84	1063.55	A	SL	No

2025	©ywesee GmbH